Lpl Financial LLC Iovance Biotherapeutics, Inc. Transaction History

Lpl Financial LLC

$196 Billion
Q2 2024

A detailed history of Lpl Financial LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 243,839 shares of IOVA stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

243,839

Previous 240,677 1.31%

Holding current value

$2.69 Million

Previous $3.57 Million 45.18%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$7.78 - $14.19 $24,600 - $44,868	3,162 Added 1.31%	243,839 $1.96 Million
Q1 2024 May 10, 2024	BUY	$7.59 - $17.47 $846,596 - $1.95 Million	111,541 Added 86.37%	240,677 $3.57 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $84,453 - $227,512	25,592 Added 24.72%	129,136 $1.05 Million
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $129,239 - $255,859	29,108 Added 39.1%	103,544 $471,000
Q2 2023 Jul 31, 2023	BUY	$5.36 - $9.06 $30,375 - $51,343	5,667 Added 8.24%	74,436 $524,000
Q1 2023 May 10, 2023	BUY	$5.53 - $8.22 $43,963 - $65,349	7,950 Added 13.07%	68,769 $420,000
Q4 2022 Feb 07, 2023	BUY	$5.62 - $10.0 $78,674 - $139,990	13,999 Added 29.9%	60,819 $388,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $11,378 - $15,653	-1,194 Reduced 2.49%	46,820 $449,000
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $146,854 - $421,919	23,018 Added 92.09%	48,014 $530,000
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $73,401 - $113,243	5,929 Added 31.1%	24,996 $416,000
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $15,854 - $26,469	958 Added 5.29%	19,067 $364,000
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $37,952 - $49,664	1,865 Added 11.48%	18,109 $447,000
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $265,264 - $537,189	16,244 New	16,244 $423,000
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $156,681 - $287,404	-5,465 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $39,368 - $70,565	-1,404 Reduced 20.44%	5,465 $254,000
Q3 2020 Nov 09, 2020	BUY	$27.75 - $36.3 $190,614 - $249,344	6,869 New	6,869 $226,000
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $450,491 - $738,102	-25,097 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$17.99 - $26.0 $451,495 - $652,522	25,097 New	25,097 $457,000

Others Institutions Holding IOVA

# of Institutions

320

Shares Held

238M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Iovance Biotherapeutics, Inc. Transaction History